Reply to Klann et al

Affiliations

¹ State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Comment

Silan Gu et al. Clin Infect Dis. 2021.

. 2021 Jun 15;72(12):2248-2249.

doi: 10.1093/cid/ciaa1194.

¹ State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

No abstract available

Comment on

Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.
Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Guo F, Zhang X, Luo R, Huang C, Lu H, Zheng B, Zhang J, Yan R, Zhang H, Jiang H, Xu Q, Guo J, Gong Y, Tang L, Li L. Gu S, et al. Clin Infect Dis. 2020 Dec 17;71(10):2669-2678. doi: 10.1093/cid/ciaa709. Clin Infect Dis. 2020. PMID: 32497191 Free PMC article.
Gut Microbiota and Coronavirus Disease 2019 (COVID-19): A Superfluous Diagnostic Biomarker or Therapeutic Target?
Klann E, Rich S, Mai V. Klann E, et al. Clin Infect Dis. 2021 Jun 15;72(12):2247-2248. doi: 10.1093/cid/ciaa1191. Clin Infect Dis. 2021. PMID: 32780788 Free PMC article. No abstract available.